Literature DB >> 19159935

Accuracy of MRI volume measurements of breast lesions: comparison between automated, semiautomated and manual assessment.

Marga B Rominger1, Daphne Fournell, Beenarose Thanka Nadar, Sarah N M Behrens, Jens H Figiel, Boris Keil, Johannes T Heverhagen.   

Abstract

The aim of this study was to investigate the efficacy of a dedicated software tool for automated and semiautomated volume measurement in contrast-enhanced (CE) magnetic resonance mammography (MRM). Ninety-six breast lesions with histopathological workup (27 benign, 69 malignant) were re-evaluated by different volume measurement techniques. Volumes of all lesions were extracted automatically (AVM) and semiautomatically (SAVM) from CE 3D MRM and compared with manual 3D contour segmentation (manual volume measurement, MVM, reference measurement technique) and volume estimates based on maximum diameter measurement (MDM). Compared with MVM as reference method MDM, AVM and SAVM underestimated lesion volumes by 63.8%, 30.9% and 21.5%, respectively, with significantly different accuracy for benign (102.4%, 18.4% and 11.4%) and malignant (54.9%, 33.0% and 23.1%) lesions (p < 0.05). Inter- and intraobserver reproducibility was best for AVM (mean difference +/- 2SD, 1.0 +/- 9.7% and 1.8 +/- 12.1%) followed by SAVM (4.3 +/- 25.7% and 4.3 +/- 7.9%), MVM (2.3 +/- 38.2% and 8.6 +/- 31.8%) and MDM (33.9 +/- 128.4% and 9.3 +/- 55.9%). SAVM is more accurate for volume assessment of breast lesions than MDM and AVM. Volume measurement is less accurate for malignant than benign lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159935     DOI: 10.1007/s00330-008-1243-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Which standard has the gold?

Authors:  C B Higgins
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

4.  Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility.

Authors:  Dag Wormanns; Gerhard Kohl; Ernst Klotz; Anke Marheine; Florian Beyer; Walter Heindel; Stefan Diederich
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

5.  MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Authors:  Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Debasish Tripathy; Dulcy S Wolverton; Hope S Rugo; E Shelley Hwang; Cheryl A Ewing; Nola M Hylton
Journal:  AJR Am J Roentgenol       Date:  2005-06       Impact factor: 3.959

6.  Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.

Authors:  Kenji Akazawa; Yasuhiro Tamaki; Tetsuya Taguchi; Yoshio Tanji; Yasuo Miyoshi; Seung Jin Kim; Satsuki Ueda; Tetsu Yanagisawa; Yoshinobu Sato; Shinichi Tamura; Shinzaburo Noguchi
Journal:  Breast J       Date:  2006 Mar-Apr       Impact factor: 2.431

7.  Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.

Authors:  Lien N Tran; Matthew S Brown; Jonathan G Goldin; Xiaohong Yan; Richard C Pais; Michael F McNitt-Gray; David Gjertson; Sarah R Rogers; Denise R Aberle
Journal:  Acad Radiol       Date:  2004-12       Impact factor: 3.173

Review 8.  Computer-aided detection and automated CT volumetry of pulmonary nodules.

Authors:  Katharina Marten; Christoph Engelke
Journal:  Eur Radiol       Date:  2006-09-20       Impact factor: 5.315

9.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Authors:  Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Dan Sudilovsky; Nola M Hylton
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

10.  Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

Authors:  Jeremy J Erasmus; Gregory W Gladish; Lyle Broemeling; Bradley S Sabloff; Mylene T Truong; Roy S Herbst; Reginald F Munden
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

View more
  6 in total

1.  Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer?

Authors:  M Rominger; D Berg; T Frauenfelder; A Ramaswamy; N Timmesfeld
Journal:  Eur Radiol       Date:  2015-08-14       Impact factor: 5.315

2.  Comparison between different imaging techniques in the evaluation of malignant breast lesions: can 3D ultrasound be useful?

Authors:  Paola Clauser; Viviana Londero; Giuseppe Como; Rossano Girometti; Massimo Bazzocchi; Chiara Zuiani
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

3.  Volume Measurement by Diffusion-Weighted Imaging in Cervical Cancer.

Authors:  Shinya Fujii; Naoki Iwata; Chie Inoue; Naoko Mukuda; Takeru Fukunaga; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

4.  Three-dimensional segmentation of breast masses from digital breast tomosynthesis images.

Authors:  Stefanie T L Pöhlmann; Yit Y Lim; Elaine Harkness; Susan Pritchard; Christopher J Taylor; Susan M Astley
Journal:  J Med Imaging (Bellingham)       Date:  2017-09-19

5.  Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response?

Authors:  Anna D'Angelo; Armando Orlandi; Enida Bufi; Sara Mercogliano; Paolo Belli; Riccardo Manfredi
Journal:  Radiol Med       Date:  2021-01-01       Impact factor: 3.469

6.  Evaluation of Breast Cancer Size Measurement by Computer-Aided Diagnosis (CAD) and a Radiologist on Breast MRI.

Authors:  Ji Yeon Park
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.